An open phase I study to assess the biological effects of a continuous intravenous infusion of interleukin-3 followed by granulocyte macrophage-colony stimulating factor
- 1 June 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (7) , 1171-1178
- https://doi.org/10.1016/0959-8049(96)00027-5
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Haemopoietic cell kinetics in humans treated with rGM‐CSFInternational Journal of Cancer, 1992
- Enhanced suppression of human myeloid leukemic cell lines by combinations of IL-6, LIF, GM-CSF and G-CSFInternational Journal of Cancer, 1990
- Clinical studies with recombinant human granulocyte-macrophage colony-stimulating factorThe International Journal of Cell Cloning, 1990
- Hematopoietic Growth FactorsNew England Journal of Medicine, 1989
- Synergistic regulation of human megakaryocyte development.Journal of Clinical Investigation, 1988
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988
- Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic SyndromesNew England Journal of Medicine, 1987
- Recombinant murine granulocyte macrophage colony-stimulating factor has megakaryocyte colony-stimulating activity and augments megakaryocyte colony stimulation by interleukin 3.Journal of Clinical Investigation, 1987
- Human IL-3 (multi-CSF): Identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3Cell, 1986
- Human Recombinant Granulocyte-Macrophage Colony-Stimulating Factor: A Multilineage HematopoietinScience, 1985